Biology Reference
In-Depth Information
Stief CG, Uckert S, Truss MC, Becker AJ, Machtens S, Jonas U (1996) A possible role for nitric
oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 24:333-337
Stief CG, Uckert S, Becker AJ, Truss MC, Jonas U (1998) Effects of specific phosphodiesterase
(PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol
159:1390-1393
Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E (2008) A randomised, placebo-controlled study
to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms
secondary to benign prostatic hyperplasia. Eur Urol 53:1236-1244
Taher A, Schulz-Knappe P, Meyer M, Truss MC, Forssmann WG, Stief CG, Jonas U (1994)
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and
their functional role in vitro. World J Urol 12:286-291
Taher A, Meyer M, Stief CG, Jonas U, Forssmann WG (1997) Cyclic nucleotide phosphodiester-
ase isoenzymes in human cavernous smooth muscle. World J Urol 15:32-35
Thadani U, Mazzu A (2002) Exercise-induced ischemia was not adversely affected by vardenafil
during exercise stress test in men with coronary artery disease. Eur Urol 1(suppl 1):151
(Abstract)
Toque HA, Teixeira CE, Lorenzetti R, Okuyama CE, Antunes E, de Nucci G (2008) Pharmaco-
logical characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor, lodenafil
carbonate, on human and rabbit corpus cavernosum. Eur J Pharmacol 591:189-195
Truss MC, Becker AJ, Djamillian MH, Stief CG, Jonas U (1994) Role of the nitric oxide donor
linsidomine chlorhydrate (SIN-1) in the diagnosis and treatment of erectile dysfunction.
Urology 44:553-556
Truss MC, Uckert S, Stief CG, Kuczyk MA, Jonas U (1996a) Cyclic nucleotide phosphodiesterase
(PDE) isoenzymes in the human detrusor smooth muscle: I. Identification and characterization.
Urol Res 24:123-128
Truss MC, Uckert S, Stief CG, Kuczyk MA, Jonas U (1996b) Cyclic nucleotide phosphodiesterase
(PDE) isoenzymes in the human detrusor smooth muscle: II. Effect of various PDE-inhibitors
on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res 24:129-134
Truss MC, Stief CG, Uckert S, Becker AJ, Wefer J, Schultheiss D, Jonas U (2001) Phosphodies-
terase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside.
World J Urol 19:344-350
Uckert S, Sandner P, Sigl K, Ulbrich E, Stief CG, Kuczyk MA (2009) Is there a role of the
phosphodiesterase type 5 (PDE5) in the control of detrusor smooth muscle? A functional and
molecular biology study. J Urol 181(suppl 4):152 (Abstract)
Uckert S, K
uthe A, Stief CG, Jonas U (2001a) Phosphodiesterase isoenzymes as pharmacological
targets in the treatment of male erectile dysfunction. World J Urol 19:14-22
Uckert S, Kuthe A, Jonas U, Stief CG (2001b) Characterization and functional relevance of cyclic
nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol 166:2484-2490
Uckert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG (2004) Interactions
between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle
tone. World J Urol 22:261-266
Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P (2006) Immunohistochemical
distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate.
Eur Urol 49:740-745
€
